Attached files
| file | filename |
|---|---|
| EX-10.1 - EX-10.1 - CANNAPHARMARX, INC. | exhibit1.htm |
| EX-10.2 - EX-10.2 - CANNAPHARMARX, INC. | exhibit2.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K/A
(Amendment No. 1)
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
| Date of Report (Date of Earliest Event Reported): | March 30, 2015 |
CannaPharmaRx, Inc.
__________________________________________
(Exact name of registrant as specified in its charter)
| Delaware | 000-27055 | 27-4635140 |
|
_____________________ (State or other jurisdiction |
_____________ (Commission |
______________ (I.R.S. Employer |
| of incorporation) | File Number) | Identification No.) |
| One Collins Drive, Suite 100, Carneys Point, New Jersey | 08069 | |
|
_________________________________ (Address of principal executive offices) |
___________ (Zip Code) |
| Registrant’s telephone number, including area code: | 856-376-0500 |
Not Applicable
______________________________________________
Former name or former address, if changed since last report
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 1.01 Entry into a Material Definitive Agreement.
As previously disclosed in the Current Report on Form 8-K filed on April 3, 2015, on March 30, 2015, CannaPharmaRx, Inc., a Delaware corporation (the "Company"), executed a Confidential Settlement and Release of Claims Agreement by and between the Company, Gary Herick, Gerald Crocker, James Smeeding, Robert Liess, Mathew Sherwood, Gary M. Cohen, CannaPharmaRX, Inc., a Colorado corporation, and each of the other parties thereto.
This Form 8-K/A amends the Current Report on Form 8-K referred to above to file Exhibit 10.1 referenced in Item 9.01 below, partially redacted while a request for confidential treatment was pending, now filed in its entirety.
The information set forth in the exhibits listed under Item 9.01 of this Current Report on Form 8-K/A is incorporated herein by reference.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits
10.1 Confidential Settlement and Release of Claims Agreement dated as of March 30,
2015 by and between the Company, Gary Herick, Gerald Crocker, James Smeeding,
Robert Liess, Mathew Sherwood, Gary M. Cohen, CannaPharmaRX, Inc., a Colorado
corporation, and each of the other parties thereto.
10.2 Metering Agreement dated as of April 1, 2015 by and among the Company and Gary
M. Cohen (included in Exhibit 10.1).
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| CannaPharmaRx, Inc. | ||||
| May 28, 2015 | By: |
/s/ Gerald E. Crocker
|
||
|
|
||||
| Name: Gerald E. Crocker | ||||
| Title: Chief Executive Officer and Director | ||||
Exhibit Index
| Exhibit No. | Description | |
|
|
|
|
|
10.1
|
Confidential Settlement and Release of Claims Agreement dated as of March 30, 2015 by and between the Company, Gary Herick, Gerald Crocker, James Smeeding, Robert Liess, Mathew Sherwood, Gary M. Cohen, CannaPharmaRX, Inc., a Colorado corporation, and each of the other parties thereto. | |
|
10.2
|
Metering Agreement dated as of April 1, 2015 by and among the Company and Gary M. Cohen (included in Exhibit 10.1). |